Across TCGA pan-cancer cohorts, ZNF736P10Y RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated ZNF736P10Y data layer.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher ZNF736P10Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF736P10Y expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.
UCS, UVM, and OV are the cancer types where ZNF736P10Y RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.